The Role of Computerized Tomography in the Assessment of Perivesical Invasion in Bladder Cancer

Overview

Journal Pol J Radiol

Publisher Termedia

Specialty Radiology

Date 2016 Jun 30

PMID 27354883

Citations 3

Authors

Ibrahim Ilker Oz

Namik Kemal Altinbas

Ismail Serifoglu

Evrim Bozay Oz

Cemil Yagci

Affiliations

Soon will be listed here.

Abstract

Background: The aim of the present study was to identify the contrast patterns of a tumor, and to evaluate the possibility of assessing the invasion of the perivesical fatty tissue in bladder cancer.

Material/methods: In this study, 26 patients with bladder cancer were included. Multiphasic CT examination was performed to determine the stage of the disease before radical cystectomy.

Results: There were statistically significant differences in tumor and perivesical fatty tissue densities between pre- and post-contrast phases (p<0.05).

Conclusions: Increases in focal density suspected of being invasion of the perivesical fatty tissue can show perivesical invasion with high specificity.

Citing Articles

The effect of different adipose tissue measurements on clinical prognosis in bladder cancer patients undergoing radical cystectomy: preliminary results.

Demirci A, Aydin H Abdom Radiol (NY). 2025; .

PMID: 39939543 DOI: 10.1007/s00261-025-04838-7.

Computed tomography-based nomogram for estimating progression-free survival probability in bladder cancer patients undergoing partial cystectomy.

Cao T, Zhu X, Guo C, Zhang H, Chen L, Zhang T Abdom Radiol (NY). 2025; .

PMID: 39862290 DOI: 10.1007/s00261-024-04747-1.

Differentiation of bladder cancer stages using the vesical imaging -reporting and data system and apparent diffusion coefficient.

Liu W, Chen R, Liu X, Zhou B, Shen Y, Zhou L Quant Imaging Med Surg. 2023; 13(8):4897-4907.

PMID: 37581052 PMC: 10423393. DOI: 10.21037/qims-22-1184.

Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy?.

Fuletra J, Watts A, Kaag M, Lehman E, Raman J, Merrill S World J Urol. 2020; 39(6):1941-1945.

PMID: 32725305 DOI: 10.1007/s00345-020-03375-w.

The role and effect of FDG-PET/CT on patient management and restaging of bladder carcinoma.

Guney I, Kucuker K, Izol V, Kibar M Turk J Urol. 2019; 45(6):423-430.

PMID: 31603416 PMC: 6788562. DOI: 10.5152/tud.2019.84453.

References

Reuter V . Bladder. Risk and prognostic factors--a pathologist's perspective. Urol Clin North Am. 1999; 26(3):481-92. DOI: 10.1016/s0094-0143(05)70196-8. View

Husband J, Olliff J, Williams M, Heron C, Cherryman G . Bladder cancer: staging with CT and MR imaging. Radiology. 1989; 173(2):435-40. DOI: 10.1148/radiology.173.2.2798874. View

Babjuk M, Burger M, Zigeuner R, Shariat S, van Rhijn B, Comperat E . EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013; 64(4):639-53. DOI: 10.1016/j.eururo.2013.06.003. View

Kim B, Semelka R, Ascher S, Chalpin D, Carroll P, Hricak H . Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology. 1994; 193(1):239-45. DOI: 10.1148/radiology.193.1.8090898. View

Hodson N, Husband J, Macdonald J . The role of computed tomography in the staging of bladder cancer. Clin Radiol. 1979; 30(4):389-95. DOI: 10.1016/s0009-9260(79)80215-9. View

Bryan P, Butler H, LiPuma J, Resnick M, Kursh E . CT and MR imaging in staging bladder neoplasms. J Comput Assist Tomogr. 1987; 11(1):96-101. DOI: 10.1097/00004728-198701000-00019. View

MacVicar A . Bladder cancer staging. BJU Int. 2000; 86 Suppl 1:111-22. DOI: 10.1046/j.1464-410x.2000.00589.x. View

Jeffrey R, Palubinskas A, Federle M . CT evaluation of invasive lesions of the bladder. J Comput Assist Tomogr. 1981; 5(1):22-6. DOI: 10.1097/00004728-198102000-00005. View

Voges G, Tauschke E, Stockle M, Alken P, Hohenfellner R . Computerized tomography: an unreliable method for accurate staging of bladder tumors in patients who are candidates for radical cystectomy. J Urol. 1989; 142(4):972-4. DOI: 10.1016/s0022-5347(17)38956-5. View

10.

Malayeri A, Pattanayak P, Apolo A . Imaging muscle-invasive and metastatic urothelial carcinoma. Curr Opin Urol. 2015; 25(5):441-8. PMC: 6771285. DOI: 10.1097/MOU.0000000000000208. View

11.

Stenzl A, Cowan N, De Santis M, Jakse G, Kuczyk M, Merseburger A . The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2009; 55(4):815-25. DOI: 10.1016/j.eururo.2009.01.002. View

12.

Kim J, Park S, Ahn H, Kim C, Cho K . Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging. Radiology. 2004; 231(3):725-31. DOI: 10.1148/radiol.2313021253. View

13.

Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H . Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol. 2011; 21(10):2178-86. DOI: 10.1007/s00330-011-2174-7. View

14.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun M . Cancer statistics, 2007. CA Cancer J Clin. 2007; 57(1):43-66. DOI: 10.3322/canjclin.57.1.43. View